Parental Decision Making in the Context of New Medical Technologies: The HPV Vaccine and its Potential Challenges

新医疗技术背景下的家长决策：HPV疫苗及其潜在挑战

• 批准号: 0724616
• 负责人: Veena Das
• 金额: $ 0.82万
• 依托单位: Johns Hopkins University
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-12-01 至 2008-11-30
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=0724616&HistoricalAwards=false
• 关键词: Parental; Decision; Making; Context; New

This project, funded by Science and Society, considers how individuals in the United States experience and interpret risk in the context of a new medical technology. The Human Papillomavirus (HPV) vaccine is the first vaccine that prevents a solely sexually-transmitted virus, considered a known cause of cervical cancer. The research will explore how and if the vaccine and its related interventions alter perceptions of risk among American women for themselves and their daughters. The HPV vaccine marks a critical shift in the health of women.Unlike most cervical cancer preventive methods of gynecological care, the vaccine targets a much younger population. The proposed research seeks to engage with questions that health intervention methods often assume, yet do not make explicit. The vaccine may soon join the ranks of required school-entry vaccines, in many ways unremarkable in its role as part of the mandated childhood vaccine series. The tension between the vaccine as novel and radical preventive possibility and its potential role as ''just another vaccine'' may evoke uncertainty for parents, policymakers, and healthcare providers.Through ethnographic methods, this project will challenge public health concepts of risk. Engaging with many of the long-standing behavioral theories, this project asks what sexual and reproductive health ''risk'' might mean for women, what counts as a health behavior, and how people define risk in their everyday lives. Over a one-year period in Los Angeles, CA, the PI will conduct archival research, ethnographic interviews, and participant observations in order to trace the effects of new technology as it moves through specific spheres of American life.

该项目由科学和社会资助，考虑了美国个人如何在新的医疗技术的背景下体验和解释风险。人乳头瘤病毒（HPV）疫苗是第一种防止仅性传播病毒的疫苗，被认为是宫颈癌的已知原因。该研究将探讨疫苗及其相关干预措施的方式以及是否改变了美国妇女对自己和女儿的风险看法。 HPV疫苗标志着女性健康的严重转变。与大多数宫颈癌预防性护理方法一样，该疫苗的目标是年轻得多。拟议的研究试图参与健康干预方法经常假设的问题，但没有明确。该疫苗可能很快就会加入所需的入学疫苗的行列，在许多方面，其作为强制性儿童疫苗系列的一部分都没有引起的影响。疫苗作为新颖和激进的预防可能性之间的张力及其作为“另一种疫苗”的潜在作用可能会引起父母，决策者和医疗保健提供者的不确定性。通过民族志方法，该项目将挑战公共卫生的风险概念。该项目涉及许多长期的行为理论，询问对女性的性和生殖健康“风险”可能意味着什么，是一种健康行为，以及人们如何在日常生活中定义风险。在加利福尼亚州洛杉矶的一年期间，PI将进行档案研究，人种学访谈和参与者的观察，以追踪新技术的影响，因为它贯穿了美国生活的特定领域。